These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 1509403)
21. Effect of heparin on the activation of factor XII and the contact system in plasma. Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067 [TBL] [Abstract][Full Text] [Related]
22. The bradykinin-forming cascade: a historical perspective. Kaplan AP Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400 [TBL] [Abstract][Full Text] [Related]
23. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock. Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027 [TBL] [Abstract][Full Text] [Related]
24. Factor XII, plasma prekallikrein, alpha 2-macroglobulin and C1-inhibitor levels in renal allograft recipients during immunosuppression with cyclosporin A--sequential measurements over four months in 17 patients. Lohri A; Huser B; Lämmle B; Oberholzer M; Thiel G; Duckert F Thromb Haemost; 1987 Dec; 58(4):993-7. PubMed ID: 2451306 [TBL] [Abstract][Full Text] [Related]
25. Contact activation during incubation of five different polyurethanes or glass in plasma. van der Kamp KW; Hauch KD; Feijen J; Horbett TA J Biomed Mater Res; 1995 Oct; 29(10):1303-6. PubMed ID: 8557733 [TBL] [Abstract][Full Text] [Related]
26. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma. Gallimore MJ; Friberger P Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564 [No Abstract] [Full Text] [Related]
27. Identification and characterization of plasma kallikrein-kinin system inhibitors from salivary glands of the blood-sucking insect Triatoma infestans. Isawa H; Orito Y; Jingushi N; Iwanaga S; Morita A; Chinzei Y; Yuda M FEBS J; 2007 Aug; 274(16):4271-86. PubMed ID: 17645545 [TBL] [Abstract][Full Text] [Related]
28. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen. Lämmle B; Berrettini M; Griffin JH Semin Thromb Hemost; 1987 Jan; 13(1):106-14. PubMed ID: 3494310 [TBL] [Abstract][Full Text] [Related]
29. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin. Espana F; Aznar J; Estelles A J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261 [TBL] [Abstract][Full Text] [Related]
30. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species. Schmaier AH; Gustafson E; Idell S; Colman RW J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352 [TBL] [Abstract][Full Text] [Related]
31. Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema. Joseph K; Tholanikunnel BG; Kaplan AP J Allergy Clin Immunol; 2017 Jul; 140(1):170-176. PubMed ID: 27826093 [TBL] [Abstract][Full Text] [Related]
32. Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment. Schapira M; Ramus MA; Waeber B; Brunner HR; Jallat S; Carvallo D; Roitsch C; Courtney M J Clin Invest; 1987 Aug; 80(2):582-5. PubMed ID: 3497179 [TBL] [Abstract][Full Text] [Related]
33. Human plasma kallikrein releases neutrophil elastase during blood coagulation. Wachtfogel YT; Kucich U; James HL; Scott CF; Schapira M; Zimmerman M; Cohen AB; Colman RW J Clin Invest; 1983 Nov; 72(5):1672-7. PubMed ID: 6556194 [TBL] [Abstract][Full Text] [Related]
34. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials. van der Kamp KW; van Oeveren W J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336 [TBL] [Abstract][Full Text] [Related]
35. Inactivation of kallikrein in human plasma. van der Graaf F; Koedam JA; Bouma BN J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384 [TBL] [Abstract][Full Text] [Related]
36. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor. Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241 [TBL] [Abstract][Full Text] [Related]
37. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein. Olson ST; Sheffer R; Francis AM Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967 [TBL] [Abstract][Full Text] [Related]
38. Structure, kinetics, and function of human and rhesus plasma prekallikreins are similar. Veloso D; Smith JI; Denny S; Cosgriff TM Thromb Haemost; 1992 Nov; 68(5):526-33. PubMed ID: 1455399 [TBL] [Abstract][Full Text] [Related]
39. Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma. Lewin MF; Kaplan AP; Harpel PC J Biol Chem; 1983 May; 258(10):6415-21. PubMed ID: 6343376 [TBL] [Abstract][Full Text] [Related]
40. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain. Page JD; You JL; Harris RB; Colman RW Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]